glp-1 optimization Glucagon-like peptide-1 receptor: mechanisms and advances in therapy 1 support Appetite GLP-1 Optimization Package – 1 pathways Multi-parameter optimization of peptides (dual

2015;62:S1524

While Mounjaro has shown promising results, it is still a newer product with relatively limited market penetration compared to the more established options from Novo

95% CI, 0.79-1.72)

This is likely because insulin resistance, insulin use, and long-standing metabolic disease can blunt weight-loss responses

Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

Researchers also face the challenge of confounding variables, since many GLP-1 users have diabetes, obesity, and high blood pressure simultaneously, all of which independently raise the risk of eye disease